Oct 27: Coherus BioSciences and Shanghai Junshi Biosciences won approval Friday for Loqtorzi (toripalimab-tpzi)in combination with cisplatin and gemcitabinefor the first-line treatment of metastatic or recurrent locally advanced nasopharyngeal carcinoma (NPC)
GLP-1 receptor agonists: A review of head-to-head clinical studies
They can be improved if your cat receives adequate amounts of B12
This is one of the strongest arguments for preferring ipamorelin over GHRP-2 or GHRP-6 in muscle-preservation contexts, where minimizing catabolic hormone exposure is a specific goal
At room temperature, the window shrinks dramatically
Even melatonin and medications that are used for short-term insomnia such as Ambien, Sonata, and Lunesta can be associated with more bad dreams, but we dont know the mechanisms. The newer GLP-1 drugs (like Ozempic and Mounjaro) that are used to treat Type 2 diabetes or promote weight loss have also been linked to disturbing dream content, Kushida adds